We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Terms of reference for the case-specific reviews that the Interim Independent Prevent Commissioner, Lord David Anderson KC has been asked to undertake.
Guidance on the collection, verification, and reporting of safety events in clinical trials of an investigational medicinal product.
Information for pregnant women with singleton (having only one baby) and twin pregnancies who have received a higher-chance result from the combined or quadruple screening test
There are changes to the legislation on reference medicinal products (RMPs) used to support abridged marketing authorisation applications.
Use a separate statement of objection form for each Japanese GI product name you object to.
This article provides a short guide on finding, reading and interpreting systematic reviews, as well as applying the results
Information about what Safety Recommendations are and how we make them as part of our investigations.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).